O018/#482 Updated Safety of Lenvatinib + Pembrolizumab Vs Treatment of Physician’s Choice in Patients with Advanced Endometrial Cancer: Study 309/Keynote-775
AuthID
P-00Y-VYP
P-00Y-VYP
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service